Related references
Note: Only part of the references are listed.3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer
Anastasia Prodromidou et al.
INFLAMMATION RESEARCH (2017)
Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies
Nan Chen et al.
Oncotarget (2017)
The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism
Yaqing Ma et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study
Tal Grenader et al.
BRITISH JOURNAL OF CANCER (2016)
Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial
Alexander Meisel et al.
EUROPEAN JOURNAL OF CANCER (2016)
Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment
Aybala Erek Toprak et al.
MEDICAL SCIENCE MONITOR (2016)
A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
Stacy B. Menees et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents
A. Romano et al.
ANNALS OF HEMATOLOGY (2015)
Neutrophil: lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study
Xiaoyan Guo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity
Cynthia E. Cherfane et al.
INFLAMMATORY BOWEL DISEASES (2015)
The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis
Ayse Kevser Demir et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2015)
Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report
Rui Liao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
C-reactive protein and lung diseases
Marianna Agassandian et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis
Mehmet Celikbilek et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2013)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity
Serkan Torun et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Regulation of Homeostasis and Inflammation in the Intestine
Thomas T. MacDonald et al.
GASTROENTEROLOGY (2011)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease patients
Serena Catarzi et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
New global map of Crohn's disease: Genetic environmental and socioeconomic correlations
Michael Economou et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
T. Kaiser et al.
GUT (2007)
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
RB Sartor
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Fecal lactoferrin: A new parameter to monitor infliximab therapy
S Buderus et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Share Paper
